The estimated Net Worth of Todd M Abbrecht is at least $2.1 Billion dollars as of 27 May 2015. Mr. Abbrecht owns over 5,000,000 units of Syneos Health Inc stock worth over $375,031,532 and over the last 13 years he sold SYNH stock worth over $1,723,510,144. In addition, he makes $255,000 as Independent Director at Syneos Health Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Abbrecht SYNH stock SEC Form 4 insiders trading
Todd has made over 11 trades of the Syneos Health Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he sold 8,725,722 units of SYNH stock worth $281,840,821 on 21 August 2015.
The largest trade he's ever made was selling 9,911,985 units of Syneos Health Inc stock on 4 April 2012 worth over $282,194,213. On average, Todd trades about 2,038,721 units every 50 days since 2011. As of 27 May 2015 he still owns at least 8,725,722 units of Syneos Health Inc stock.
You can see the complete history of Mr. Abbrecht stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Todd Abbrecht biography
Todd M. Abbrecht serves as Independent Director of the Company. Since 1992, Mr. Abbrecht has served in various roles at THL, a private equity firm, where he is currently the Head of Private Equity and is a member of the firm’s management committee. Prior to joining THL, Mr. Abbrecht worked at Credit Suisse First Boston in its mergers and acquisitions department. Mr. Abbrecht currently serves on the board of directors of CSafe Global, Juvare Holdings, Inc., Party City Holdco (NYSE:PRTY) (Compensation Committee member), PCI Pharma Services Inc. (Compensation Committee member) and Professional Physical Therapy, Inc. (Compensation Committee member). Mr. Abbrecht is also currently a member of the board of trustees of Joslin Diabetes Center. Mr. Abbrecht previously served on the board of directors of Aramark Holdings Corp. (NYSE: ARMK), Fogo de Chao (formerly Nasdaq: FOGO), Curo Health Services, Inc., Healthcare Staffing Services, Inc., and Intermedix Corporation. Mr. Abbrecht earned his BSE in finance from the Wharton School of the University of Pennsylvania and his MBA from Harvard Business School.
What is the salary of Todd Abbrecht?
As the Independent Director of Syneos Health Inc, the total compensation of Todd Abbrecht at Syneos Health Inc is $255,000. There are 16 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of $7,646,360.
How old is Todd Abbrecht?
Todd Abbrecht is 50, he's been the Independent Director of Syneos Health Inc since 2017. There are 11 older and 7 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.
What's Todd Abbrecht's mailing address?
Todd's mailing address filed with the SEC is C/O THOMAS H. LEE PARTNERS, L.P., 100 FEDERAL STREET, 35TH FLOOR, BOSTON, MA, 02110.
Insiders trading at Syneos Health Inc
Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado, and Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.
What does Syneos Health Inc do?
inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.
What does Syneos Health Inc's logo look like?
Complete history of Mr. Abbrecht stock trades at Dunkin Brands Inc, Aramark, and Syneos Health Inc
Syneos Health Inc executives and stock owners
Syneos Health Inc executives and other stock owners filed with the SEC include:
-
Alistair Macdonald,
Chief Executive Officer, Director -
Jason Meggs,
Chief Financial Officer -
Paul Colvin,
President - Clinical Solutions -
Michelle Keefe,
President - Commercial Solutions -
Jonathan Olefson,
General Counsel, Corporate Secretary -
Alistair Macdonald,
CEO & Director -
Jason M. Meggs,
Chief Financial Officer -
Paul D. Colvin,
Chief Bus. Officer -
Michelle Keefe,
Pres of Commercial Solutions -
Jonathan Olefson,
Gen. Counsel & Corp. Sec. -
John Dineen,
Independent Chairman of the Board -
William Klitgaard,
Independent Director -
Kenneth Meyers,
Independent Director -
Linda Harty,
Independent Director -
Matthew Monaghan,
Independent Director -
Joshua Nelson,
Independent Director -
Todd Abbrecht,
Independent Director -
Bernadette Connaughton,
Independent Director -
Thomas Allen,
Independent Director -
John Maldonado,
Independent Director -
Ronnie Speight,
Senior Vice President, Investor Relations -
Robert Parks,
Executive Vice President, Chief Accounting Officer -
Lisa van Capelle,
Chief Human Resource Officer -
Dr. Judith Ng-Cashin M.D.,
Chief Scientific Officer -
Kristen Spensieri,
Global Head of Corp. Communications & Marketing -
Larry A. Pickett Jr.,
Chief Information & Digital Officer -
Dr. Judith Ng-Cashin,
Chief Scientific Officer -
Donna Hildebrand Kralowetz,
Sr. VP of Fin. & Principal Accounting Officer -
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Ma Doubl...,
-
Tom Allen,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Christopher L Gaenzle,
CAO, GC & Sec -
Michael Adam Bell,
Director -
Joshua M Nelson,
-
Todd M Abbrecht,
-
H. Lee Advisors, Llcthl Hol...,
-
H. Lee Advisors, Llc Thomas...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llc Thomas...,
-
H. Lee Advisors, Llcthl Fun...,
-
H. Lee Equity Fund Vi, L.P....,
-
Christian Tucat,
Chief Business Officer -
Michael Lee Brooks,
Chief Operating Officer -
Barbara W. Bodem,
Director -
Alfonso G Zulueta,
Director -
Stanford Rudnick,
See remarks -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
Michael J. Bonello,
Chief Financial Officer -
Donna Hildebrand Kralowetz,
EVP, Chief Accounting Officer -
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
International Corp/Ma Adven...,
-
H. Lee Advisors, Llcthl Fun...,
-
International Corp/Maap Gpe...,
-
International Corp/Maap Gpe...,
-
David S. Wilkes,
Director